IRIS
SANTILLI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.804
EU - Europa 5.285
AS - Asia 5.042
SA - Sud America 746
AF - Africa 68
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 4
Totale 18.964
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.636
SG - Singapore 2.047
CN - Cina 1.504
IE - Irlanda 949
IT - Italia 842
UA - Ucraina 781
SE - Svezia 694
TR - Turchia 690
BR - Brasile 623
GB - Regno Unito 549
DE - Germania 404
FR - Francia 391
VN - Vietnam 266
FI - Finlandia 249
IN - India 238
RU - Federazione Russa 176
CA - Canada 95
PL - Polonia 64
HK - Hong Kong 61
AR - Argentina 60
MX - Messico 54
JP - Giappone 37
NL - Olanda 37
AT - Austria 35
ZA - Sudafrica 33
BD - Bangladesh 29
IQ - Iraq 26
ES - Italia 25
KR - Corea 24
ID - Indonesia 21
CZ - Repubblica Ceca 18
BE - Belgio 16
EC - Ecuador 16
MA - Marocco 12
AZ - Azerbaigian 11
EU - Europa 11
IR - Iran 11
LT - Lituania 11
PK - Pakistan 11
VE - Venezuela 10
AL - Albania 9
CL - Cile 9
CO - Colombia 8
IL - Israele 8
RO - Romania 8
UZ - Uzbekistan 8
JO - Giordania 6
OM - Oman 6
PE - Perù 6
PY - Paraguay 6
QA - Qatar 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
UY - Uruguay 5
EG - Egitto 4
KE - Kenya 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AU - Australia 3
BA - Bosnia-Erzegovina 3
BZ - Belize 3
CH - Svizzera 3
DK - Danimarca 3
DZ - Algeria 3
ET - Etiopia 3
GR - Grecia 3
HU - Ungheria 3
LK - Sri Lanka 3
NG - Nigeria 3
NP - Nepal 3
RS - Serbia 3
BG - Bulgaria 2
BO - Bolivia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
HN - Honduras 2
JM - Giamaica 2
KG - Kirghizistan 2
LB - Libano 2
PH - Filippine 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TN - Tunisia 2
AO - Angola 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CU - Cuba 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
Totale 18.959
Salva come PNG Salva come JPEG
Città #
Singapore 1.539
Chandler 1.086
Jacksonville 959
Dublin 935
Ashburn 644
Dallas 518
Beijing 428
Princeton 383
Southend 370
Izmir 335
Los Angeles 235
Nanjing 235
Dearborn 205
Santa Clara 203
The Dalles 192
Wilmington 185
New York 165
Cambridge 159
Ann Arbor 144
Altamura 134
Chieti 107
Munich 105
Nanchang 99
Tongling 99
Ho Chi Minh City 95
Boardman 88
Buffalo 85
Pescara 75
São Paulo 70
Washington 64
Helsinki 59
Hong Kong 58
Redondo Beach 57
Hanoi 54
Shenyang 49
Hebei 48
Brooklyn 47
Kunming 47
Montreal 44
Woodbridge 44
Tianjin 42
Warsaw 37
Rome 35
Tokyo 35
Turku 34
Orem 33
Changsha 31
Jiaxing 31
Denver 30
Grevenbroich 30
Seattle 30
Hefei 29
Norwalk 29
Stockholm 28
Augusta 27
London 27
Moscow 27
Poplar 27
Chicago 26
Milan 26
Johannesburg 24
Toronto 24
Seoul 23
Nuremberg 22
Chennai 21
Frankfurt am Main 21
Ankara 19
Atlanta 19
Houston 19
Boston 18
Dong Ket 18
Jinan 18
Mexico City 18
Changchun 17
Lanzhou 17
Phoenix 17
San Mateo 17
Brussels 16
Hangzhou 16
Amsterdam 15
Falls Church 15
San Francisco 15
Vienna 15
Brno 14
Manchester 14
Querétaro 14
Rio de Janeiro 14
Belo Horizonte 13
Council Bluffs 13
Mumbai 13
Shanghai 13
Brasília 12
Curitiba 11
Guangzhou 11
Lappeenranta 11
Baku 10
Charlotte 10
Leawood 10
Pune 10
Vancouver 10
Totale 11.689
Salva come PNG Salva come JPEG
Nome #
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 159
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 159
Pentraxin 3 and platelet activation in obese patients after gastric banding 156
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 153
Long-term Positivity to SARS-CoV-2: A Clinical Case of COVID-19 with Persistent Evidence of Infection 146
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 141
Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients 140
Role of growth factors in the development of diabetic complications 140
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 139
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 138
Determinants of platelet activation in hypertensives with microalbuminuria. 137
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 135
Oxidative-induced membrane damage in diabetes lymphocytes: effects on intracellular Ca2+ homeostasis 135
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 134
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 132
A case of coinfection with SARS-COV-2 and Cytomegalovirus in the Era of Covid-19 132
24-months follow-up to assess the efficacy and tolerability of evolocumab in a young patient with chronic and progressive ischemic arteriopathy 128
Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. 127
Association of low-grade inflammation and platelet activation in hypertensive patients with microalbuminuria 126
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 126
Platelets and Diabetes 126
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 126
Significance of urinary 11-dehydro-thromboxane B2 in age-related diseases: Focus on atherothrombosis 125
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes. 125
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 124
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 123
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 122
Arterial stiffness and sedentary lifestyle: Role of oxidative stress 122
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 121
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes 121
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 120
Neurocognitive impairment and suicide risk among prison inmates 120
Livelli circolanti di adiponectina e interleuchina-10 nell’obesità di tipo androide. 119
Effects of vitamin E supplementation on intracellular antioxidant enzyme production in adolescents with type 1 diabetes and early microangiopathy. 118
Platelets and diabetes mellitus 118
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 118
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 117
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 117
The role of antileukotrienes in the treatment of asthma. 116
Coagulation and infective endocarditis: sooner or later 116
Post-traumatic stress in pregnant women with primary cytomegalovirus infection and risk of congenital infection in newborns. 116
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 115
Decreased plasma soluble rage in patients with hypercholesterolemia: effects of statins. 115
CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. 114
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 114
Insulin resistance as a determinant of platelet activation in obese women. 113
Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy 113
Determinants of increased cardiovascular disease in obesity and metabolic syndrome. 113
Effects of high-amount-high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis 112
Platelet activation in obesity and metabolic syndrome. 111
Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach. 111
Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study 111
Aspirin, platelets, and cancer: The point of view of the internist. 110
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 109
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 109
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 109
Enhanced soluble CD40 Ligand is responsible for endothelial dysfunction and monocyte activation in patients with diabetes mellitus. Effect of improved metabolic control. 108
Basophil Activation Test with Different Polyethylene Glycols in Patients with Suspected PEG Hypersensitivity Reactions 108
The role of nitric oxide in the development of diabetic angiopathy. 107
Soluble forms of RAGE in human diseases: clinical and therapeutical implications. 107
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 107
Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis. 107
Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: Effects of anti-TNFα treatment 107
Thromboxane-dependent platelet activation in obese subjects with prediabetes or early type 2 diabetes: Effects of liraglutide-or lifestyle changes-induced weight loss 107
Subcutaneous adipose tissue elastosonography in obese patients: a preliminary report 107
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 106
The deadly line linking sympathetic overdrive, dipping status and vascular risk: Critical appraisal and therapeutic implications 106
Determinants of platelet activation in hypertensives with microalbuminuria. 105
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro 105
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 104
Circulating Myeloid-Related Protein-8/14 is Related to Thromboxane-Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low-Dose Aspirin Treatment. 104
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 104
Soluble forms of RAGE in internal medicine. 104
Soluble RAGE in type 2 diabetes: association with oxidative stress. 102
Atherothrombotic disease and the metabolic syndrome. 102
Antiplatelet Agents. Thromboxane receptors antagonists and/or synthase inhibitors 102
COVID-19 and RAS: Unravelling an Unclear Relationship 102
Lopinavir/ritonavir and darunavir/cobicistat in hospitalized covid-19 patients: Findings from the multicenter italian corist study 101
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study 101
Thromboxane-dependent CD40L release in type 2 diabetes mellitus 100
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 100
A Complex Interaction between Rickettsia conorii and Dickkopf-1 - Potential Role in Immune Evasion Mechanisms in Endothelial Cells 100
From Endothelium to Lipids, Through microRNAs and PCSK9: A Fascinating Travel Across Atherosclerosis 100
Aspirin as antiplatelet agent in diabetes. PROS-. 100
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control. 99
Association between PAI-1 and Oxidative Stress in Android Obesity 99
Extracellular vesicles number and cell subtype may be influenced by diabetes mellitus and metformin in patients at high cardiovascular risk 99
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 98
Attivazione piastrinica e stress ossidativo in vivo nell’artrite reumatoide. 97
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 97
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 97
Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study 97
Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus 95
Insulin resistance as a determinant of platelet activation in obese women 94
Diabetes mellitus in the pre-school child. 94
The left atrial appendage: from embryology to prevention of thromboembolism 94
Oxidant stress as a major determinant of platelet activation in invasive breast cancer 94
Association between enhanced soluble CD40 ligand and platelet activation in hypertensives with microalbuminuria. 94
Increased Vascular Endothelial Growth Factor Serum Concentrations May Help to Identify Patients with Onset of Type 1 Diabetes during Childhood at risk for Developing Persistent Microalbuminuria 93
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 92
Totale 11.438
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.584
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.584
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021617 0 0 0 0 0 242 31 28 102 140 38 36
2021/20221.005 29 26 10 175 76 43 39 75 97 55 112 268
2022/20232.957 232 426 180 284 276 596 160 240 377 36 86 64
2023/20241.741 104 44 119 51 131 551 363 107 39 51 25 156
2024/20253.743 242 703 577 88 92 172 144 172 350 174 451 578
2025/20264.190 651 337 908 1.086 901 307 0 0 0 0 0 0
Totale 20.094